Systemic therapy rates in patients with lung cancer have fallen short of published benchmarks, especially for people low income groups, according to a NSW study. The study, published in the Asia-Pacific Journal of Clinical Oncology, comprised more than 1,000 patients with different types of lung cancer. PBS claims data showed 45% of patients overall received ...
Socioeconomic disparities impact on uptake of chemo for lung cancer
By Mardi Chapman
15 Jul 2021